431 related articles for article (PubMed ID: 28807705)
1. Psychometric Properties of the Fatigue Questionnaire EORTC QLQ-FA12 in a Sample of Female Cancer Patients.
Kecke S; Ernst J; Einenkel J; Singer S; Hinz A
J Pain Symptom Manage; 2017 Dec; 54(6):922-928. PubMed ID: 28807705
[TBL] [Abstract][Full Text] [Related]
2. International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12).
Weis J; Tomaszewski KA; Hammerlid E; Ignacio Arraras J; Conroy T; Lanceley A; Schmidt H; Wirtz M; Singer S; Pinto M; Alm El-Din M; Compter I; Holzner B; Hofmeister D; Chie WC; Czeladzki M; Harle A; Jones L; Ritter S; Flechtner HH; Bottomley A;
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28376231
[TBL] [Abstract][Full Text] [Related]
3. Fatigue in the general population: German normative values of the EORTC QLQ-FA12.
Hinz A; Weis J; Brähler E; Mehnert A
Qual Life Res; 2018 Oct; 27(10):2681-2689. PubMed ID: 29909484
[TBL] [Abstract][Full Text] [Related]
4. Fatigue in breast cancer patients: psychometric evaluation of the fatigue questionnaire EORTC QLQ-FA13.
Fuhrmann K; Mehnert A; Geue K; Hinz A
Breast Cancer; 2015 Nov; 22(6):608-14. PubMed ID: 24633470
[TBL] [Abstract][Full Text] [Related]
5. Psychometric properties of the fatigue questionnaire EORTC QLQ-FA12 and proposal of a cut-off value for young adults with cancer.
Friedrich M; Nowe E; Hofmeister D; Kuhnt S; Leuteritz K; Sender A; Stöbel-Richter Y; Geue K
Health Qual Life Outcomes; 2018 Jun; 16(1):125. PubMed ID: 29903021
[TBL] [Abstract][Full Text] [Related]
6. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity to change of the EORTC quality of life module measuring cancer-related fatigue (EORTC QlQ-Fa12): Results from the international psychometric validation.
Weis J; Wirtz MA; Tomaszewski KA; Hammerlid E; Arraras JI; Conroy T; Lanceley A; Schmidt H; Singer S; Pinto M; Alm El-Din M; Compter I; Holzner B; Hofmeister D; Chie WC; Harle A; Flechtner HH; Bottomley A;
Psychooncology; 2019 Aug; 28(8):1753-1761. PubMed ID: 31225669
[TBL] [Abstract][Full Text] [Related]
8. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors.
Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S
Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917
[TBL] [Abstract][Full Text] [Related]
9. Reliability and Validity of Amharic Version of EORTC QLQ-C 30 Questionnaire among Gynecological Cancer Patients in Ethiopia.
Ayana BA; Negash S; Yusuf L; Tigeneh W; Haile D
PLoS One; 2016; 11(6):e0157359. PubMed ID: 27304066
[TBL] [Abstract][Full Text] [Related]
10. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
[TBL] [Abstract][Full Text] [Related]
11. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
12. Is it useful to calculate sum scores of the quality of life questionnaire EORTC QLQ-C30?
Hinz A; Einenkel J; Briest S; Stolzenburg JU; Papsdorf K; Singer S
Eur J Cancer Care (Engl); 2012 Sep; 21(5):677-83. PubMed ID: 22624663
[TBL] [Abstract][Full Text] [Related]
13. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
[TBL] [Abstract][Full Text] [Related]
14. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
[TBL] [Abstract][Full Text] [Related]
15. Psychometric properties of the Arabic version of EORTC QLQ-C15-PAL among cancer patients in Jordan.
Alawneh A; Yasin H; Khirfan G; Qayas BA; Ammar K; Rimawi D; Klepstad P
Support Care Cancer; 2016 Jun; 24(6):2455-62. PubMed ID: 26660151
[TBL] [Abstract][Full Text] [Related]
16. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
[TBL] [Abstract][Full Text] [Related]
17. Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning.
Petersen MA; Groenvold M; Aaronson NK; Chie WC; Conroy T; Costantini A; Fayers P; Helbostad J; Holzner B; Kaasa S; Singer S; Velikova G; Young T;
Eur J Cancer; 2010 May; 46(8):1352-8. PubMed ID: 20231085
[TBL] [Abstract][Full Text] [Related]
18. Validation study of the EORTC information questionnaire (EORTC QLQ-INFO25) in Iranian cancer patients.
Asadi-Lari M; Ahmadi Pishkuhi M; Almasi-Hashiani A; Safiri S; Sepidarkish M
Support Care Cancer; 2015 Jul; 23(7):1875-82. PubMed ID: 25475735
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.
Demirci S; Eser E; Ozsaran Z; Tankisi D; Aras AB; Ozaydemir G; Anacak Y
Asian Pac J Cancer Prev; 2011; 12(5):1283-7. PubMed ID: 21875283
[TBL] [Abstract][Full Text] [Related]
20. Psychometric properties of the EORTC QLQ-C30 in Uganda.
Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L
Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
